Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Option Award | 2024-01-03 7:33 pm | N/A 2033-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-03 3:58 pm | N/A 2031-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 1:47 pm | N/A 2031-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 5:28 pm | N/A 2030-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-20 9:05 pm | N/A 2030-01-30 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 6,125 | $0 | 6,125 (Direct) | View |
| 2019-11-26 Exercise | 2019-11-26 7:40 pm | N/A 2027-12-31 | Monopar Therapeutics | RIOUX PATRICE Acting Chief Medical Officer | 18,433 | $0 | 59,004 (Direct) | View | |
| 2019-11-26 Exercise | 2019-11-26 7:40 pm | N/A N/A | Monopar Therapeutics | RIOUX PATRICE Acting Chief Medical Officer | 100 | $0.001 | 59,004 (Direct) | View | |
| 2019-11-26 Exercise | 2019-11-26 7:40 pm | N/A N/A | Monopar Therapeutics | RIOUX PATRICE Acting Chief Medical Officer | 18,333 | $6 | 59,004 (Direct) | View |